Quality of life effects of intermittent and continuous hormonal therapy by cyproterone acetate (CPA) for metastatic prostate cancer (abstract 541) - Verhagen, P CMS; Wissenburg, L D; Wildhagen, M F (2008)
Presented at: 23rd Annual Congress of the European Association of Urology; March 26–29